Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress

BACKGROUND: FGF21 is a promising intervention therapy for metabolic diseases as fatty liver, obesity and diabetes. Recent results suggest that FGF21 is highly expressed in hepatocytes under metabolic stress caused by starvation, hepatosteatosis, obesity and diabetes. Hepatic FGF21 elicits metabolic...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yang, Chaofeng, Lu, Weiqin, Lin, Tao, You, Pan, Ye, Min, Huang, Yanqing, Jiang, Xianhan, Wang, Cong, Wang, Fen, Lee, Mong-Hong, Yeung, Sai-Ching J, Johnson, Randy L, Wei, Chongjuan, Tsai, Robert Y, Frazier, Marsha L, McKeehan, Wallace L, Luo, Yongde
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637159/
https://ncbi.nlm.nih.gov/pubmed/23590285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-13-67
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky